At the molecular level, ATXN8OS sponged a tumor-suppressive miR-424-5p, thereby activating key oncogenes such as EYA1, DACH1, and CHRM3, which could be suppressed by Rg3 treatment. The gene discussed is CHRM3; the disease is neoplasm.